Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 340 results for "pfizer"

Pfizer Q1 net dips 3% at Rs 46 cr
Money Control

Pfizer Q1 Net Dips 3 Per Cent at Rs 46 Crore

New Delhi: Drug firm Pfizer on Thursday reported a 3.10 per cent decline in net profit at Rs 46.15 crore for the first quarter that ended on June 30, 2014. The company had posted a net profit of Rs 47.63 crore for the corresponding quarter a year ... NDTV Profit, 1 hour ago
Pfizer Q1 Net dips 3% at Rs 46 cr Business Standard, 36 minutes ago

2,655 images for pfizer

American Banking News, 1 day ago, 37 minutes ago
Pharma Letter, 19 hours ago
Money Control, 1 hour ago
Bidness Etc, 1 week ago
Treasury Today, 5 days ago
Pharmafocus, 6 days ago, 5 days ago
International Business Times Australia, 1 day ago
Motley Fool, 2 days ago

Pfizer Q1 net drops 3% to Rs46 crore

Shares of Pfizer on Thursday closed at Rs1,412.05 apiece on the BSE, down 0.45% from previous close. Photo: AFP New Delhi: Drug firm Pfizer Ltd on Thursday reported a 3.10% decline in net profit at Rs. 46.15 crore for the quarter ended June 30. ...
 Livemint.com1 hour ago
Yahoo! Finance

These deals may suffer in US 'inversion' crackdown

Pfizer/AstraZeneca Pfizer ( PFE ) , the U.S. big pharma giant, first embarked on its pursuit of the U.K.'s AstraZeneca (London Stock Exchange: AZN-GB) last year, but was forced into the open in April. It faced high-profile criticism from ...
 Yahoo! Finance1 hour ago
Pharma Letter

Pfizer backs out of funding Puma cancer drug trials

16:56 ET | About: Pfizer Inc. (PFE) Pfizer (PFE +0.5%) amends its license agreement with Puma Biotechnology (PBYI +0.1%) for Puma's investigational cancer drug PB272. The latter is developing the product for the treatment of HER2-positive breast ...
 Seeking Alpha1 day ago Puma Biotech rockets on new neratinib data; amends deal with Pfizer23-07-2014  Pharma Letter20 hours ago Pfizer Inc. Backs Out of Funding Puma Biotechnology Cancer Drug Trials  BioSpace21 hours ago Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx  Industrial Info Financials1 day ago
Caribbean Business Online

Ad campaign on aging gets hipper with new acronym

Pfizer is revamping its $3 million a year "Get Old" initiative, aimed at stimulating conversations on aging and longevity, by augmenting its ad campaign with a new acronym, FOGO, aka fear of getting old, and adding content on social media platforms ...
 Caribbean Business Online3 hours ago

Prempro Lawyers Double Money in $62 Million Fee Fight

Lawyers who battled Pfizer Zoe Littlepage and Rainey Booth, who won a half-dozen verdicts for women who blamed their breast cancer on Prempro and other menopause medicines, are slated to receive more than $21.8 million in fees under the ...
 BusinessWeek17 hours ago Prempro Plaintiffs Lawyers Settle $62 Million Fee Fight  Bloomberg21 hours ago

Pfizer (PFE) Trading Near $30.84 Resistance Level

The patented option-trade picking algorithms that power's Artificial Intelligence Center have selected a covered-call trade on Pfizer Inc. ("PFE) that includes 4.53% ...
 Individual.com22 hours ago Potential Pfizer (PFE) Trade Has 4.09% Downside Protection  Individual.com1 day ago Potential Pfizer (PFE) Trade Targets 3.27% Return  Individual.com5 days ago Potential Pfizer (PFE) Trade Has 5.60% Downside Protection  Individual.com2 days ago

07.22.14 -- Pfizer To Buy InnoPharma, Acquires Injectables Portfolio

SPONSOR PMMI has joined forces with ISPE to introduce Pharma EXPO 2014. Making its debut in November 2014, Pharma EXPO will bring together as many as 10,000 pharmaceutical, biopharmaceutical, and medical device manufacturers for conference ...
 Pharmaceutical Online1 day ago

Pesquisa da Pfizer mostra que Viagra é mais acessível do que se imagina

SO PAULO, 22 de julho de 2014 /PRNewswire/ -- Uma pesquisa realizada pelo IMS Consulting Group com 281 homens brasileiros mostrou que eles têm uma percepção equivocada sobre o preço do Viagra, primeiro medicamento do mercado para tratar ...
 PR Newswire1 day ago

Pfizer Issues Positive Top-Line Results from Phase 3 Study of NONACOG ALFA

Pfizer reported the positive results of a Phase 3 study comparing a prophylaxis regimen of BeneFIX Coagulation Factor IX (Recombinant) 100 IU/kg once-weekly to on-demand treatment in people with moderately severe to severe hemophilia B. According to ...
 Individual.com3 days ago Pfizer : Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA BeneFIX® Once-Weekly Prophylaxis For Hemophilia B  4 Traders10 hours ago Pfizer announces positive results from Phase III hemophilia B study  Individual.com6 days ago Pfizer's phase 3 study of BeneFIX meets primary endpoint to treat hemophilia B  PharmaBiz6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - pfizer
Get updated on latest news & your favorite topics right in your inbox!
More     Less